Mitchell P. Kopin 13D and 13G filings for Phio Pharmaceuticals Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 4:46 pm Purchase | 2025-12-31 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 1,142,556 9.100% | 712,556 (+165.71%) | Filing |
| 2025-11-07 5:27 pm Sale | 2025-09-30 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 430,000 7.000% | -100,171 (-18.89%) | Filing |
| 2025-01-17 4:44 pm Purchase | 2025-01-13 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 530,171 9.990% | 439,184 (+482.69%) | Filing |
| 2024-12-27 5:05 pm Purchase | 2024-12-19 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 90,987 4.990% | 45,782 (+101.28%) | Filing |
| 2024-11-13 11:20 am Sale | 2024-09-30 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 45,205 4.990% | -53,840 (-54.36%) | Filing |